EDWARDS LIFESCIENCES CORP (1EW.MI) Stock Fundamental Analysis

BIT:1EW • US28176E1082

65.35 EUR
-5.41 (-7.65%)
Last: Feb 10, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

7

1EW gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 65 industry peers in the Health Care Equipment & Supplies industry. 1EW gets an excellent profitability rating and is at the same time showing great financial health properties. 1EW is valied quite expensively at the moment, while it does show a decent growth rate. With these ratings, 1EW could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year 1EW was profitable.
  • In the past year 1EW had a positive cash flow from operations.
  • 1EW had positive earnings in each of the past 5 years.
  • Each year in the past 5 years 1EW had a positive operating cash flow.
1EW.MI Yearly Net Income VS EBIT VS OCF VS FCF1EW.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

1.2 Ratios

  • With an excellent Return On Assets value of 10.31%, 1EW belongs to the best of the industry, outperforming 89.55% of the companies in the same industry.
  • With a decent Return On Equity value of 13.40%, 1EW is doing good in the industry, outperforming 77.61% of the companies in the same industry.
  • The Return On Invested Capital of 1EW (12.50%) is better than 89.55% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for 1EW is significantly above the industry average of 9.73%.
Industry RankSector Rank
ROA 10.31%
ROE 13.4%
ROIC 12.5%
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)15.82%
ROIC(5y)17.27%
1EW.MI Yearly ROA, ROE, ROIC1EW.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

  • 1EW has a Profit Margin of 23.25%. This is amongst the best in the industry. 1EW outperforms 92.54% of its industry peers.
  • In the last couple of years the Profit Margin of 1EW has grown nicely.
  • 1EW has a better Operating Margin (27.73%) than 97.01% of its industry peers.
  • In the last couple of years the Operating Margin of 1EW has remained more or less at the same level.
  • Looking at the Gross Margin, with a value of 78.19%, 1EW belongs to the top of the industry, outperforming 92.54% of the companies in the same industry.
  • 1EW's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 27.73%
PM (TTM) 23.25%
GM 78.19%
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
1EW.MI Yearly Profit, Operating, Gross Margins1EW.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

10

2. Health

2.1 Basic Checks

  • 1EW has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for 1EW has been reduced compared to 1 year ago.
  • The number of shares outstanding for 1EW has been reduced compared to 5 years ago.
  • Compared to 1 year ago, 1EW has an improved debt to assets ratio.
1EW.MI Yearly Shares Outstanding1EW.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
1EW.MI Yearly Total Debt VS Total Assets1EW.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • 1EW has an Altman-Z score of 11.49. This indicates that 1EW is financially healthy and has little risk of bankruptcy at the moment.
  • 1EW's Altman-Z score of 11.49 is amongst the best of the industry. 1EW outperforms 92.54% of its industry peers.
  • The Debt to FCF ratio of 1EW is 0.75, which is an excellent value as it means it would take 1EW, only 0.75 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.75, 1EW belongs to the top of the industry, outperforming 91.04% of the companies in the same industry.
  • 1EW has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
  • 1EW has a Debt to Equity ratio of 0.06. This is amongst the best in the industry. 1EW outperforms 85.07% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.75
Altman-Z 11.49
ROIC/WACC1.25
WACC9.99%
1EW.MI Yearly LT Debt VS Equity VS FCF1EW.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

  • 1EW has a Current Ratio of 4.00. This indicates that 1EW is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 4.00, 1EW belongs to the best of the industry, outperforming 92.54% of the companies in the same industry.
  • A Quick Ratio of 3.29 indicates that 1EW has no problem at all paying its short term obligations.
  • 1EW's Quick ratio of 3.29 is amongst the best of the industry. 1EW outperforms 92.54% of its industry peers.
Industry RankSector Rank
Current Ratio 4
Quick Ratio 3.29
1EW.MI Yearly Current Assets VS Current Liabilites1EW.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • 1EW shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.75%.
  • 1EW shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.13% yearly.
  • The Revenue has been growing slightly by 4.67% in the past year.
  • 1EW shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.58% yearly.
EPS 1Y (TTM)-3.75%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%0%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%14.67%

3.2 Future

  • The Earnings Per Share is expected to grow by 9.40% on average over the next years. This is quite good.
  • Based on estimates for the next years, 1EW will show a quite strong growth in Revenue. The Revenue will grow by 8.47% on average per year.
EPS Next Y1.27%
EPS Next 2Y6.53%
EPS Next 3Y7.87%
EPS Next 5Y9.4%
Revenue Next Year4.63%
Revenue Next 2Y7.15%
Revenue Next 3Y8.06%
Revenue Next 5Y8.47%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
1EW.MI Yearly Revenue VS Estimates1EW.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
1EW.MI Yearly EPS VS Estimates1EW.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 29.84, the valuation of 1EW can be described as expensive.
  • 1EW's Price/Earnings ratio is in line with the industry average.
  • When comparing the Price/Earnings ratio of 1EW to the average of the S&P500 Index (27.10), we can say 1EW is valued inline with the index average.
  • The Price/Forward Earnings ratio is 25.83, which means the current valuation is very expensive for 1EW.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of 1EW is on the same level as its industry peers.
  • When comparing the Price/Forward Earnings ratio of 1EW to the average of the S&P500 Index (28.06), we can say 1EW is valued inline with the index average.
Industry RankSector Rank
PE 29.84
Fwd PE 25.83
1EW.MI Price Earnings VS Forward Price Earnings1EW.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 1EW's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. 1EW is more expensive than 61.19% of the companies in the same industry.
  • 1EW's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 55.74
EV/EBITDA 22.46
1EW.MI Per share data1EW.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • 1EW has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)23.47
PEG (5Y)4.18
EPS Next 2Y6.53%
EPS Next 3Y7.87%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • 1EW does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EDWARDS LIFESCIENCES CORP

BIT:1EW (2/10/2026, 7:00:00 PM)

65.35

-5.41 (-7.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-30
Earnings (Next)02-10
Inst Owners89.94%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap37.92B
Revenue(TTM)5.88B
Net Income(TTM)1.37B
Analysts79.52
Price Target82.88 (26.82%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.01%
Min EPS beat(2)4.4%
Max EPS beat(2)9.63%
EPS beat(4)4
Avg EPS beat(4)5.38%
Min EPS beat(4)3.4%
Max EPS beat(4)9.63%
EPS beat(8)5
Avg EPS beat(8)2.27%
EPS beat(12)6
Avg EPS beat(12)1.21%
EPS beat(16)7
Avg EPS beat(16)-0.18%
Revenue beat(2)1
Avg Revenue beat(2)0.37%
Min Revenue beat(2)-0.12%
Max Revenue beat(2)0.85%
Revenue beat(4)1
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-2.1%
Max Revenue beat(4)0.85%
Revenue beat(8)1
Avg Revenue beat(8)-4.64%
Revenue beat(12)2
Avg Revenue beat(12)-3.41%
Revenue beat(16)2
Avg Revenue beat(16)-3.45%
PT rev (1m)1.89%
PT rev (3m)7%
EPS NQ rev (1m)-0.25%
EPS NQ rev (3m)-1.76%
EPS NY rev (1m)0.84%
EPS NY rev (3m)5.07%
Revenue NQ rev (1m)0.31%
Revenue NQ rev (3m)3.04%
Revenue NY rev (1m)0.29%
Revenue NY rev (3m)3.76%
Valuation
Industry RankSector Rank
PE 29.84
Fwd PE 25.83
P/S 7.58
P/FCF 55.74
P/OCF 43.83
P/B 4.37
P/tB 6.1
EV/EBITDA 22.46
EPS(TTM)2.19
EY3.35%
EPS(NY)2.53
Fwd EY3.87%
FCF(TTM)1.17
FCFY1.79%
OCF(TTM)1.49
OCFY2.28%
SpS8.63
BVpS14.96
TBVpS10.71
PEG (NY)23.47
PEG (5Y)4.18
Graham Number27.15
Profitability
Industry RankSector Rank
ROA 10.31%
ROE 13.4%
ROCE 13.97%
ROIC 12.5%
ROICexc 18.63%
ROICexgc 29.56%
OM 27.73%
PM (TTM) 23.25%
GM 78.19%
FCFM 13.59%
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)15.82%
ROIC(5y)17.27%
ROICexc(3y)20.51%
ROICexc(5y)22.13%
ROICexgc(3y)29.09%
ROICexgc(5y)31.03%
ROCE(3y)17.66%
ROCE(5y)19.29%
ROICexgc growth 3Y-5.47%
ROICexgc growth 5Y-8.01%
ROICexc growth 3Y-11.82%
ROICexc growth 5Y-8.6%
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
F-Score6
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.75
Debt/EBITDA 0.33
Cap/Depr 138.79%
Cap/Sales 3.69%
Interest Coverage 250
Cash Conversion 56.86%
Profit Quality 58.45%
Current Ratio 4
Quick Ratio 3.29
Altman-Z 11.49
F-Score6
WACC9.99%
ROIC/WACC1.25
Cap/Depr(3y)185.14%
Cap/Depr(5y)236.01%
Cap/Sales(3y)5.48%
Cap/Sales(5y)6.41%
Profit Quality(3y)37.92%
Profit Quality(5y)57.13%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.75%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%0%
EPS Next Y1.27%
EPS Next 2Y6.53%
EPS Next 3Y7.87%
EPS Next 5Y9.4%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%14.67%
Revenue Next Year4.63%
Revenue Next 2Y7.15%
Revenue Next 3Y8.06%
Revenue Next 5Y8.47%
EBIT growth 1Y4.68%
EBIT growth 3Y-4.72%
EBIT growth 5Y3.49%
EBIT Next Year13.12%
EBIT Next 3Y12.54%
EBIT Next 5Y12.3%
FCF growth 1Y1.45%
FCF growth 3Y-42.99%
FCF growth 5Y-22.01%
OCF growth 1Y-2.42%
OCF growth 3Y-32.1%
OCF growth 5Y-14.39%

EDWARDS LIFESCIENCES CORP / 1EW.MI FAQ

Can you provide the ChartMill fundamental rating for EDWARDS LIFESCIENCES CORP?

ChartMill assigns a fundamental rating of 7 / 10 to 1EW.MI.


What is the valuation status of EDWARDS LIFESCIENCES CORP (1EW.MI) stock?

ChartMill assigns a valuation rating of 2 / 10 to EDWARDS LIFESCIENCES CORP (1EW.MI). This can be considered as Overvalued.


How profitable is EDWARDS LIFESCIENCES CORP (1EW.MI) stock?

EDWARDS LIFESCIENCES CORP (1EW.MI) has a profitability rating of 8 / 10.


What is the valuation of EDWARDS LIFESCIENCES CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for EDWARDS LIFESCIENCES CORP (1EW.MI) is 29.84 and the Price/Book (PB) ratio is 4.37.


What is the expected EPS growth for EDWARDS LIFESCIENCES CORP (1EW.MI) stock?

The Earnings per Share (EPS) of EDWARDS LIFESCIENCES CORP (1EW.MI) is expected to grow by 1.27% in the next year.